Contact this trialFirst, we need to learn more about you.
Selective Estrogen Receptor Modulator
Tamoxifen for Breast Cancer Risk Reduction
Recruiting1 awardPhase 2
Chicago, Illinois
This trial is testing a low dose of tamoxifen to see if it can reduce breast density in women who have a higher risk of breast cancer. Breast density is a known risk factor for breast cancer
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service